Indaba Capital Management L.P. 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:32 pm Sale | 2024-09-30 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 2,641,379 0.700% | -5,333,995 (-66.88%) | Filing |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,975,374 9.900% | 80,623 (+1.02%) | Filing |
| 2023-02-14 10:26 am Purchase | 2022-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,894,751 9.900% | 308,846 (+4.07%) | Filing |
| 2022-02-14 3:46 pm Purchase | 2021-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,585,905 9.900% | 49,555 (+0.66%) | Filing |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,536,350 9.900% | 257,826 (+3.54%) | Filing |
| 2020-02-14 3:31 pm Purchase | 2019-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,278,524 9.900% | 7,278,524 (New Position) | Filing |